Cartesian Therapeutics Inc (RNAC)

01:08 AM

AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate - Benzinga

01:08 AM

07:40 AM

Cartesian Therapeutics, Inc. (RNAC) Moves 9.9% Higher: Will This Strength Last? - Yahoo Finance

07:40 AM

Jul 23, 2025

Is Cartesian Therapeutics Inc. a good long term investmentFree Stock Market Return Analysis - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Cartesian Therapeutics Inc. Stock Analysis and ForecastFree Daily Trading Room Entry - Autocar Professional

Jul 23, 2025

Jul 22, 2025

What drives Cartesian Therapeutics Inc. stock priceRapid growth trajectories - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What analysts say about Cartesian Therapeutics Inc. stockFree Stock Market Forecast Reports - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What makes Cartesian Therapeutics Inc. stock price move sharplyFree Stock Market Swing Trading Strategies - Newser

Jul 22, 2025

Jul 22, 2025

Multiple Myeloma Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis CASI Pharmaceuticals, Carsgen Therapeutics, Cartesian Therapeutics - MenaFN

Jul 22, 2025

Jul 15, 2025

Why Cartesian Therapeutics Inc. stock attracts strong analyst attentionCarefully Curated High Return Stocks - Newser

Jul 15, 2025

Jul 15, 2025

How Cartesian Therapeutics Inc. stock performs during market volatilityShort Squeeze Radar - Newser

Jul 15, 2025

Jul 12, 2025

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives $40.00 Average Price Target from Analysts - Defense World

Jul 12, 2025

Jul 12, 2025

What is Wedbush’s Estimate for RNAC Q2 Earnings? - Defense World

Jul 12, 2025

Jul 11, 2025

Cartesian Therapeutics Advances mRNA CAR T-cell Therapy for Myasthenia Gravis - TipRanks

Jul 11, 2025

Jul 11, 2025

Wedbush Initiates Coverage on Cartesian Therapeutics (NASDAQ:RNAC) - Defense World

Jul 11, 2025

Jul 10, 2025

CartesianAutoimmune Cell Therapy Excites, But Reality Bites (NASDAQ:RNAC) - Seeking Alpha

Jul 10, 2025

Jul 10, 2025

CAR T-Cell Therapies at a Crossroads: LICATS Challenges and the Rise of Cartesian Therapeutics in Autoimmune Markets - AInvest

Jul 10, 2025

Jul 09, 2025

Wedbush initiates coverage on Cartesian Therapeutics stock with Outperform rating - Investing.com Canada

Jul 09, 2025

Jul 09, 2025

Cartesian stock up as Wedbush becomes bullish (RNAC:NASDAQ) - Seeking Alpha

Jul 09, 2025

Jul 09, 2025

Cartesian Therapeutics' 15min chart sees KDJ Golden Cross, bullish Marubozu formation. - AInvest

Jul 09, 2025

Jun 30, 2025

AbbVie Makes Big Autoimmune CAR-T Play With Capstan Acquisition - insights.citeline.com

Jun 30, 2025

Jun 28, 2025

What caused RNAC's earnings to miss forecasts in Q4 2023? - AInvest

Jun 28, 2025

Jun 26, 2025

Rhumbline Advisers Grows Stock Position in Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World

Jun 26, 2025

Jun 21, 2025

We're Not Very Worried About Cartesian Therapeutics' (NASDAQ:RNAC) Cash Burn Rate - Yahoo Finance

Jun 21, 2025

Jun 18, 2025

Myasthenia Gravis Market to Expand Significantly by 2034, States DelveInsight Report | Sanofi, Cartesian Therapeutics, Takeda, UCB Biopharma, Hoffmann-La Roche, Janssen Research & Development, LLC - The Globe and Mail

Jun 18, 2025

Jun 18, 2025

IBM Introduces Industry-First Software to Unify Agentic Governance and Security - The Globe and Mail

Jun 18, 2025

Jun 16, 2025

Cartesian Therapeutics holds annual stockholders meeting By Investing.com - Investing.com South Africa

Jun 16, 2025

Jun 16, 2025

Cartesian Therapeutics holds annual stockholders meeting - Investing.com

Jun 16, 2025

Jun 16, 2025

Cartesian Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 16, 2025

Jun 16, 2025

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Shares Acquired by Bank of America Corp DE - Defense World

Jun 16, 2025

Jun 14, 2025

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jun 14, 2025

Jun 13, 2025

Two Sigma Investments LP Reduces Holdings in Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World

Jun 13, 2025

Jun 11, 2025

Equities Analysts Offer Predictions for RNAC FY2026 Earnings - Defense World

Jun 11, 2025

Jun 05, 2025

Nuveen Asset Management LLC Buys 47,889 Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World

Jun 05, 2025

Jun 04, 2025

Cartesian Therapeutics Announces New Employment Inducement Grants - GlobeNewswire

Jun 04, 2025

Jun 03, 2025

Cartesian Therapeutics Announces New Employment Inducement Grants | RNAC Stock News - GuruFocus

Jun 03, 2025

Jun 03, 2025

Cartesian Therapeutics (RNAC) Issues Inducement Stock Options to New Employees | RNAC Stock News - GuruFocus

Jun 03, 2025